References
- 1Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 10th ed. Oxford, England: Blackwell Science, 1997:390–415.
- 2Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda, MD:American Association of Blood Banks 1996:473.
- 3Konugres AA.Rh immune globulin. In: Churchill WH,Kurtz SR, eds. Transfus Med. Boston: Blackwell Scientific Publications, 1988:315–25.
- 4Bowman JM, Pollack JM. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures. Transfus Med Rev 1987;1:101–12.
- 5Mollison PL. Some aspects of Rh hemolytic disease and its prevention. In: Garratty G, ed. Hemolytic disease of the newborn. Arlington, VA: American Association of Blood Banks, 1984:1–32.
- 6Mollison PL. Blood transfusion in clinical medicine. 6th ed. Oxford, England: Blackwell Scientific Publications, 1979:345.
- 7Pollack W, Ascari WQ, Kochesky RJ,et al. Studies on Rh prophylaxis. I. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971;11:333–9.
- 8Pollack W, Ascari WQ,Crispen JF,et al. Studies on Rh prophylaxis. II. Rh immune prophylaxis after transfusion with Rh positive blood. Transfusion 1971;11:340–4.
- 9Contreras M, Mollison PL. Failure to augment primary Rh immunization using a small dose of ‘passive’ IgG anti-Rh. Br J Haematol 1981;49:371–81.
- 10Contreras M, Mollison PL.Rh immunization facilitated by passively-administered anti-Rh? Br J Haematol 1983;53:153–9.
- 11Bowman JM. Historical overview: hemolytic disease of the fetus and newborn.In:Kennedy MS,Wilson S, Kelton JG, eds. Perinatal transfusion medicine. Arlington,VA:American Association of Blood Banks, 1990:1–52.